讯飞医疗2025年年报

ANNUAL REPORT2025年 報 Contents目錄 Definition2Corporate Information7Financial Highlights10Management Discussion and Analysis11Directors and Senior Management54Corporate Governance Report67Directors’ Report89Independent Auditor’s Report120Consolidated Statement of Profit or Loss and Other Comprehensive Income128Consolidated Statement of Financial Position129Consolidated Statement of Changes in Equity131Consolidated Statement of Cash Flows132Notes to the Consolidated Financial Statements134 NAME OF THE COMPANYCHINESE NAME Xunfei Healthcare Technology Co., Ltd. ENGLISH NAMEXunfei Healthcare Technology Co., Ltd. DIRECTORSEXECUTIVE DIRECTORDr. Tao Xiaodong(General Manager) NON-EXECUTIVE DIRECTORSDr. Liu Qingfeng(Chairman)Mr. Zhao ZhiweiMr. Duan Dawei INDEPENDENT NON-EXECUTIVE DIRECTORS Prof. Wang YangProf. Zhao HuifangMr. Tan Ching AUDIT COMMITTEEProf. Zhao Huifang(Chairwoman)Prof. Wang YangMr. Duan Dawei REMUNERATION COMMITTEE Prof. Zhao Huifang(Chairwoman)Mr. Zhao ZhiweiMr. Tan Ching NOMINATION COMMITTEE Dr. Liu Qingfeng(Chairman)Prof. Zhao HuifangMr. Tan Ching Corporate Information公司資料 ESG ENVIRONMENTAL, SOCIAL AND GOVERNANCE(ESG) COMMITTEE Dr. Liu Qingfeng(Chairman)Dr. Tao XiaodongProf. Wang Yang JOINT COMPANY SECRETARIESDr. Liu WeiMs. Yeung Siu Lam AUTHORISED REPRESENTATIVESDr. Tao XiaodongDr. Liu Wei REGISTERED OFFICE AND HEAD OFFICE IN THEPRC 666145 4 to 5/F (North Area), No.1 BuildingiFLYTEK AI Research and Development Production Base (Phase I)No. 666 Science and Innovation Road,Chengxiqiao Community Services Center, High-tech ZoneHefei City, Anhui ProvincePRC PRINCIPAL PLACE OF BUSINESS IN HONG KONG Room 1922, 19/F, Lee Garden One33 Hysan AvenueCauseway BayHong Kong 33191922 H1617 H SHARE REGISTRAR Tricor Investor Services Limited17/F, Far East Finance Centre16 Harcourt RoadHong Kong STOCK CODE2506 2506 https://www.iflyhealth.com/ COMPANY’S WEBSITEhttps://www.iflyhealth.com/ INDEPENDENT AUDITOR 8835 Deloitte Touche TohmatsuCertified Public AccountantsRegistered Public Interest Entity Auditors35/F, One Pacific Place88 QueenswayHong Kong LEGAL ADVISORS TO OUR COMPANY 27 As to Hong Kong law:Clifford Chance27/F, Jardine HouseOne Connaught PlaceCentralHong Kong 13662805 As to PRC law:CM Law FirmRoom 2805, Plaza 66 Tower 2No. 1366 Nanjing West RoadShanghaiPRC PRINCIPAL BANKS 848 Huishang Bank Hefei High-Tech Zone BranchNo. 848 Changjiang West RoadShushan DistrictHefei, Anhui ProvincePRC 169 China Merchants Bank Hefei Sanxiaokou BranchCMB BuildingNo. 169 Funan RoadLuyang DistrictHefei, Anhui ProvincePRC COMPLIANCE ADVISOR 2920 Somerley Capital Limited20/F, China Building29 Queen’s Road CentralHong Kong Financial Highlights財務摘要 Thefollowing is a summary of the results and assets andliabilities of our Group for the past five financial years: Management Discussion and Analysis管理層討論與分析 2025AIAIAIAIGBCAI In2025,large language models in healthcare continuedtoachieve technological break throughs.The training andinference efficiency of domestically developed general-purposelargemodels improved significantly,while the capabilities ofindustry-specific medical models grew steadily. All have led tothe maturing of AI applications in the healthcare sector. A seriesof supportive policies at the national level have promoted thedeep integration of AI with public health, clinical diagnosis andtreatment,and health management.These policies provide asolid regulatory foundation and broad development space forthe Company to deepen its presence in the smart healthcaremarket. Driven by technology innovation, policy support, and thedemand for high-quality healthcare development, the healthcareAI market maintains a positive outlook. Leveraging its leadingmedical large model technology and medical knowledge system,the Company continues to strengthen its core advantages. Ithas upgraded its two product lines–the AI Intelligent Assistantandthe AI Health Assistant–with large models at the core,buildinga GBC full-scenario AI empowerment matrix thatcovers governments, hospitals, and individuals. The Companyhas achieved tangible results in assisting industry supervision,improvinghospital operational ef ficiency,and suppor tingresidents’ health management, laying a solid foundation for itssustained high-quality development. CORE TECHNOLOGIES GBCAIAI2023 Relyingon its self-developed Spark Medical Model andauthoritative medical knowledge base, the Company has builtaGBC multi-terminal product matrix covering government,hospitals,and individual users.It continuously iterates coreproductssuch as the AI Intelligent Assistant and AI HealthAssistant, comprehensively empowering government regulatoryoversight, improving hospital quality and efficiency, and personalhealthmanagement,thereby accelerating Xunfei Healthcare’sprogress towards becoming a global leader in the healthcareindustry. Since the release of the industry’s only medical largemodeltrained on fully domestic computing power in 2023,the Co